I thought today’s CC was the best one GTC has ever had. I especially liked the newfound emphasis on follow-on biologics, a business model we’ve discussed on this board but one that had not previously been highlighted by GTC itself.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”